Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Theolytics, a clinical‑stage biotechnology company developing next‑generation oncolytic immunotherapies, announces that it has relocated to new, state‑of‑the‑art facilities at ARC Oxford, a growing science and innovation campus close to Oxford’s world‑class research institutes, teaching hospitals and university. The company joins a thriving community of more than 30 science and technology companies at ARC Oxford, further strengthening the campus’ position as a hub for cutting‑edge innovation.

Load More